Injectable Drug Delivery Market Size, Share and Industry Analysis By Device Type (Conventional Injectable, Pre-filled Syringes, Auto-injectors, Pen-injectors, Others), By Application (Autoimmune Disorders, Diabetes, Pain Management, Aesthetic Treatments, Others), By Route of Administration (Subcutaneous, Intravenous, Intramuscular, Others), By End-User (Hospitals, Home Care Settings, Clinics, Others), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Injectable Drug Delivery Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Injectable Drug Delivery market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Injectable Drug Delivery market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Injectable Drug Delivery Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Injectable Drug Delivery Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Injectable Drug Delivery Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
BD
  
SHL Group
  
Insulet Corporation
  
Elcam Medical
  
Pfizer Inc
  
Eli Lilly and Company
  
West Pharmaceutical Services, Inc
  
Ypsomed AG
  
Gerresheimer AG
  
Others

Report Coverage

Injectable drug delivery has become an utmost crucial element in the administration of therapeutics drugs for autoimmune diseases, diabetes, pain management, and other disorders. Injectable drug delivery systems are also important for aesthetic treatments like skin tightening, body shaping, wrinkle treatments, etc. Vaccinations, antibiotics, and other liquid drugs can now be safely introduced in the patient through various routes such as subcutaneous, intravenous, or intramuscular. Because of these advancements, the healthcare industry is providing more innovative systems for patient convenience, the effectiveness of drugs, and treatment against health disorders.
The injectable drug delivery market report provides qualitative and quantitative insights on the industry trends and detailed analysis of market size and growth rate for all possible segments in the market. The market segment includes device type, application, route of administration, end-user, and geography. Based on devices type, the global market for injectable drug delivery segments include conventional injectable, pre-filled syringes, auto-injectors, pen injectors, and others.

Based on the application, the global market segments include autoimmune disorders, diabetes, pain management, aesthetic treatments, and others. Based on the route of administration, the global market segments include subcutaneous, intravenous, intramuscular, and others. Based on end-user, the global market segments include hospitals, home care settings, clinics, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The regions are further categorized into countries.

Along with this, the report analysis includes market dynamics and competitive landscape. Various key insights provided in the report are the prevalence of key diseases by key countries, new product launch, technological advancements, recent industry developments such as mergers & acquisitions, pricing analysis of key players, and others.

SEGMENTATION

By Device Type

  
Conventional Injectable
  
Pre-filled Syringes
  
Auto-injectors
  
Pen-injectors
  
Others

By Application

  
Autoimmune Disorders
  
Diabetes
  
Pain Management
  
Aesthetic Treatments
  
Others

By Route of Administration

  
Subcutaneous
  
Intravenous
  
Intramuscular
  
Others

By End-User

  
Hospitals
  
Home Care Settings
  
Clinics
  
Others

By Geography

  
North America (the USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Key Industry Developments

In July 2019, EVER NEURO PHARMA GMBH launched a D-MINE pump for patients of Parkinsons disease. The device provides continuous subcutaneous drug delivery and is convenient for patient use.

In June 2018, AbbVie Inc. and Eisai Co., Ltd., launched an auto-injector for Humira drug response in the treatment of autoimmune diseases.

In November 2017, West Pharmaceutical Services, Inc., launched a new extension of the SMARTDOSE drug delivery platform including wearable injectors.